Algert Global’s Nuvalent NUVL Stock Holding History

Algert Global’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,650	Closed	-$1.54M	–	1289
2024 Q4	$1.54M	Buy	+19,650	New	+$1.84M	0.04%	690
2024 Q3	–	Sell	-2,954	Closed	-$224K	–	1451
2024 Q2	$224K	Buy	+2,954	New	+$210K	0.01%	1237

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Algert Global's NUVL Position: Q1 2025 in Review

Algert Global sold out of Nuvalent (NUVL) in Q1 2025, closing a stake of 19,650 shares — an estimated $1.54M sold.

Algert Global first reported a position in NUVL in Q2 2024 and held it in 2 quarters. The position peaked at $1.54M in Q4 2024. 205 funds tracked by Wall St. Rank hold NUVL as of Q1 2025.

Algert Global reported no remaining Nuvalent position as of Q1 2025 after selling out during the quarter.
Algert Global sold 19,650 Nuvalent shares in Q1 2025, an estimated $1.54M.
Algert Global first reported a position in Nuvalent in Q2 2024 and held it in 2 quarters.
Algert Global's Nuvalent position peaked at $1.54M in Q4 2024.
205 funds tracked by Wall St. Rank held Nuvalent as of Q1 2025.

Based on Algert Global's 13F filing for Q1 2025, filed 13 May 2025.